TScan Therapeutics Inc
TCRX1.695USD
+0.075+4.63%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
USD0.000Vorbörsliches Trading (ET)
95.92MMarktkapitalisierung
VerlustKGV TTM
TScan Therapeutics Inc
1.695
+0.075+4.63%
Vierteljährlich
Vierteljährlich+Jährlich
Vierteljährlich
Jährlich
YOY
Leere Zeilen ausblenden
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Gesamteinnahmen
283.57%2.17M
-90.78%665.00K
-73.01%1.05M
-82.97%536.00K
-91.68%566.00K
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.80M
8.44%3.10M
39.43%3.36M
42.42%4.06M
49.04%3.02M
258.99%2.85M
731.72%2.41M
--2.85M
--2.03M
--795.00K
--290.00K
--0.00
--0.00
Umsatz
283.57%2.17M
-90.78%665.00K
-73.01%1.05M
-82.97%536.00K
-91.68%566.00K
132.99%7.21M
15.58%3.89M
-22.39%3.15M
125.19%6.80M
8.44%3.10M
39.43%3.36M
42.42%4.06M
49.04%3.02M
258.99%2.85M
731.72%2.41M
--2.85M
--2.03M
--795.00K
--290.00K
--0.00
--0.00
Betriebskosten
20.29%38.42M
30.84%37.38M
17.59%33.67M
24.83%34.65M
8.10%31.94M
31.38%28.57M
43.60%28.64M
43.81%27.76M
54.01%29.55M
27.49%21.74M
9.24%19.94M
42.69%19.30M
92.90%19.18M
98.21%17.06M
144.66%18.25M
140.87%13.53M
76.45%9.95M
--8.61M
--7.46M
--5.62M
--5.64M
Forschung und Entwicklungskosten
17.82%29.29M
31.01%29.35M
15.48%26.26M
26.62%26.88M
14.13%24.86M
43.59%22.41M
51.29%22.74M
46.45%21.23M
48.26%21.78M
23.76%15.60M
5.81%15.03M
34.19%14.49M
100.16%14.69M
111.40%12.61M
144.38%14.21M
139.92%10.80M
70.75%7.34M
--5.96M
--5.81M
--4.50M
--4.30M
Abschreibungen und Amortisationen
-45.93%678.00K
-44.45%711.00K
-20.14%1.03M
-13.89%1.12M
-16.34%1.25M
-13.75%1.28M
2.80%1.29M
7.37%1.30M
25.44%1.50M
29.95%1.48M
18.47%1.25M
82.60%1.21M
154.80%1.20M
188.38%1.14M
205.20%1.06M
148.50%661.00K
111.26%469.00K
--396.00K
--346.00K
--266.00K
--222.00K
Betriebsgewinn
-15.55%-36.25M
-71.90%-36.71M
-31.82%-32.62M
-38.62%-34.11M
-37.95%-31.37M
-14.52%-21.36M
-49.28%-24.75M
-61.42%-24.61M
-40.71%-22.74M
-31.31%-18.65M
-4.65%-16.58M
-42.77%-15.25M
-104.13%-16.16M
-81.84%-14.20M
-120.92%-15.84M
-90.15%-10.68M
-40.49%-7.92M
---7.81M
---7.17M
---5.62M
---5.64M
Netto nicht-operative Zinsen (Aufwendungen)
Nicht betriebliche Zinserträge
27.95%2.80M
6.97%2.78M
35.13%3.69M
121.97%3.41M
92.78%2.19M
188.12%2.60M
411.80%2.73M
929.53%1.53M
16128.57%1.14M
44950.00%901.00K
17700.00%534.00K
2880.00%149.00K
16.67%7.00K
-33.33%2.00K
200.00%3.00K
66.67%5.00K
-93.94%6.00K
--3.00K
--1.00K
--3.00K
--99.00K
Nicht operative Zinsaufwendungen
-29.20%679.00K
-7.98%784.00K
-2.44%958.00K
-1.75%952.00K
0.31%959.00K
-12.62%852.00K
388.56%982.00K
--969.00K
--956.00K
--975.00K
--201.00K
----
----
----
----
----
----
----
----
----
----
Besondere Erträge (Aufwendungen)
----
---1.09M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Einkommen vor Steuern
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Einkommen nach Steuern
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Nettoeinkommen aus fortgeführten Geschäftsbereichen
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Auf Anteilseigner entfallender Nettogewinn
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Nettoeinkommen, das den Stammaktionären zuzurechnen ist
-13.22%-34.13M
-82.58%-35.81M
-29.96%-29.89M
-31.67%-31.66M
-33.59%-30.14M
-4.75%-19.61M
-41.56%-23.00M
-59.27%-24.05M
-39.66%-22.56M
-31.85%-18.72M
-2.56%-16.25M
-41.44%-15.10M
-104.20%-16.16M
-81.89%-14.20M
-120.91%-15.84M
-90.17%-10.67M
-42.89%-7.91M
---7.81M
---7.17M
---5.61M
---5.54M
Gewinn pro Aktie
17.16%-0.26
-43.92%-0.30
-3.83%-0.25
45.19%-0.28
65.89%-0.32
73.52%-0.21
64.06%-0.24
18.82%-0.51
-38.21%-0.93
-29.17%-0.78
-0.49%-0.67
-38.64%-0.63
-100.90%-0.67
-81.89%-0.60
-120.91%-0.67
-90.17%-0.45
-42.89%-0.34
---0.33
---0.30
---0.24
---0.23
Verwässerter Gewinn pro Aktie
17.16%-0.26
-43.92%-0.30
-3.83%-0.25
45.19%-0.28
65.89%-0.32
73.52%-0.21
64.06%-0.24
18.82%-0.51
-38.21%-0.93
-29.17%-0.78
-0.49%-0.67
-38.64%-0.63
-100.90%-0.67
-81.89%-0.60
-120.91%-0.67
-90.17%-0.45
-42.89%-0.34
---0.33
---0.30
---0.24
---0.23
Dividende je Aktie
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Währungseinheit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Prüfungsmeinungen
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
KeyAI